BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2485243)

  • 1. Cell proliferation and expression of cytokeratin filaments in F9 embryonal carcinoma cells.
    Kurki P; Laasonen A; Tan EM; Lehtonen E
    Development; 1989 Aug; 106(4):635-40. PubMed ID: 2485243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuron-like derivatives of cultured F9 embryonal carcinoma cells express characteristics of parietal endoderm cells.
    Tienari J; Virtanen I; Soinila S; Lehtonen E
    Dev Biol; 1987 Oct; 123(2):566-73. PubMed ID: 2820818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in calcitonin and parathyroid hormone responsiveness of adenylate cyclase in F9 embryonal carcinoma cells treated with retinoic acid and dibutyryl cyclic AMP.
    Evain D; Binet E; Anderson WB
    J Cell Physiol; 1981 Dec; 109(3):453-9. PubMed ID: 6274880
    [No Abstract]   [Full Text] [Related]  

  • 4. Posttranscriptional regulation of the expression of CAD gene during differentiation of F9 teratocarcinoma cells by induction with retinoic acid and dibutyryl cyclic AMP.
    Rao GN; Church RL; Davidson JN
    FEBS Lett; 1988 May; 232(1):238-42. PubMed ID: 2896607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth and differentiation of embryonal carcinoma cell line F9 in defined media.
    Rizzino A; Crowley C
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):457-61. PubMed ID: 6244561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of vinculin plaques precedes other cytoskeletal changes during retinoic acid-induced teratocarcinoma cell differentiation.
    Lehtonen E; Lehto VP; Badley RA; Virtanen I
    Exp Cell Res; 1983 Mar; 144(1):191-7. PubMed ID: 6188622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditions affecting the differentiation of F9 teratocarcinoma cells: potentiation of response by cyclic AMP.
    Grover A; Adamson ED
    In Vitro Cell Dev Biol; 1986 May; 22(5):280-4. PubMed ID: 2423499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro differentiation of mouse teratocarcinoma cells monitored by intermediate filament expression.
    Paulin D; Jakob H; Jacob F; Weber K; Osborn M
    Differentiation; 1982; 22(2):90-9. PubMed ID: 6182048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of new proteins of the intermediate filament protein family in differentiating F9 embryonal carcinoma cell cytoskeleton.
    Lampron C; Royal A
    J Biol Chem; 1987 Apr; 262(10):4893-8. PubMed ID: 3558376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular HSP90 (HSP86) mRNA level and in vitro differentiation of mouse embryonal carcinoma (F9) cells.
    Kohda T; Kondo K; Oishi M
    FEBS Lett; 1991 Sep; 290(1-2):107-10. PubMed ID: 1655528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation between loss of anchorage-independent growth and levels of transformation-specific p53 protein in retinoic acid-treated F9 embryonal carcinoma cells.
    Rodrigues M; Balicki D; Newrock KM; Mukherjee BB
    Exp Cell Res; 1985 Jan; 156(1):22-30. PubMed ID: 2981174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The growth and morphological characteristics of undifferentiated and differentiated cells of the F9 mouse teratocarcinoma line].
    Kisliakova TV; Pospelova TV; Pospelov VA
    Tsitologiia; 1990; 32(1):54-60. PubMed ID: 1973862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a parathyroid hormone-like protein and its receptor during differentiation of embryonal carcinoma cells.
    Chan SD; Strewler GJ; King KL; Nissenson RA
    Mol Endocrinol; 1990 Apr; 4(4):638-46. PubMed ID: 2177844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of keratin filaments in embryonic epithelial cell types.
    Trevor KT
    New Biol; 1990 Nov; 2(11):1004-14. PubMed ID: 1714295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of alpha 6/beta 1 integrin expression during differentiation of F9 murine embryonal carcinoma cells to parietal endoderm.
    Morini M; Piccini D; Barbieri O; Astigiano S
    Exp Cell Res; 1997 May; 232(2):304-12. PubMed ID: 9168806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratin filament expression during in vitro teratocarcinoma cell differentiation as detected by a monoclonal antibody.
    Ramaekers F; Schaap H; Mulder M; Huysmans A; Vooijs P
    Cell Biol Int Rep; 1984 Sep; 8(9):721-30. PubMed ID: 6209018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid-induced transition from protein kinase C beta to protein kinase C alpha in differentiated F9 cells: correlation with altered regulation of proto-oncogene expression by phorbol esters.
    Khuri FR; Cho Y; Talmage DA
    Cell Growth Differ; 1996 May; 7(5):595-602. PubMed ID: 8732669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin filament expression during in vitro teratocarcinoma cell differentiation as detected by a monoclonal antibody.
    Ramaekers F; Schaap H; Mulder M; Huysmans A; Vooijs P
    Cell Biol Int Rep; 1984 Jun; 8(6):507-18. PubMed ID: 6204783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible effects of dibutyryl cAMP on laminin and type IV collagen secretion from retinoic acid treated F9 cells.
    Morita A; Kitagawa Y; Sugimoto E
    J Cell Physiol; 1985 Nov; 125(2):263-72. PubMed ID: 2997239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of fibroblast growth factor by F9 teratocarcinoma cells as a function of differentiation.
    Braunhut SJ; Gudas LJ; Kurokawa T; Sasse J; D'Amore PA
    J Cell Biol; 1989 Jun; 108(6):2467-76. PubMed ID: 2544608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.